loadpatents
name:-0.026071071624756
name:-0.03496789932251
name:-0.020251035690308
TRILLIUM THERAPEUTICS INC Patent Filings

TRILLIUM THERAPEUTICS INC

Patent Applications and Registrations

Patent applications and USPTO patent grants for TRILLIUM THERAPEUTICS INC.The latest application filed is for "biomarkers for cd47 blockade therapy".

Company Profile
30.34.48
  • TRILLIUM THERAPEUTICS INC - Mississauga CA
  • TRILLIUM THERAPEUTICS INC. - Mississauga CA
  • TRILLIUM THERAPEUTICS INC. - Toronto CA
  • Trillium Therapeutics, Inc. - Martinsried DE
  • Trillium Therapeutics Inc. - CA CA
  • TRILLIUM THERAPEUTICS, INC. - 96 Skyway Avenue Toronto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biomarkers For Cd47 Blockade Therapy
App 20220289821 - Johnson; Lisa Danae Schultz ;   et al.
2022-09-15
Cd47 Blockade With Parp Inhibition For Disease Treatment
App 20210315864 - Johnson; Lisa Danae Schultz ;   et al.
2021-10-14
Cd47 Blockade With Radiation Therapy
App 20210244816 - Cui; Lei ;   et al.
2021-08-12
Treatment Of Cd47+ Disease Cells With Sirp Alpha-fc Fusions
App 20210206829 - Uger; Robert Adam ;   et al.
2021-07-08
Cd47 Blockade Therapy With Cd38 Antibody
App 20210040224 - LIN; Gloria Hoi Ying ;   et al.
2021-02-11
Improvements In Cd47 Blockade Therapy By Egfr Antibody
App 20210040219 - LIN; Gloria Hoi Ying ;   et al.
2021-02-11
Treatment of CD47+ disease cells with SIRP.alpha.-Fc fusions
Grant 10,906,954 - Uger , et al. February 2, 2
2021-02-02
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
Grant 10,696,670 - Slassi , et al. June 30, 2
2020-06-30
Fluorinated Amide Derivatives And Their Uses As Therapeutic Agents
App 20200181067 - Slassi; Abdelmalik
2020-06-11
Cd47 Blockade Therapy
App 20200157179 - LIN; Gloria Hoi Ying ;   et al.
2020-05-21
Fluorinated amide derivatives and their uses as therapeutic agents
Grant 10,604,476 - Slassi
2020-03-31
Heteroaromatic-fused Imidazolyl Amides, Compositions And Uses Thereof As Sting Agonists
App 20200031825 - Slassi; Abdelmalik ;   et al.
2020-01-30
Heterocycle Derivatives And Their Use For The Treatment Of Cns Disorders
App 20190367466 - Slassi; Abdelmalik
2019-12-05
Heterocycle derivatives and their use for the treatment of CNS disorders
Grant 10,428,030 - Slassi October 1, 2
2019-10-01
Improvements In Cd47 Blockade Therapy By Hdac Inhibitors
App 20190269756 - Linderoth; Emma ;   et al.
2019-09-05
Enhancement Of Cd47 Blockade Therapy By Proteasome Inhibitors
App 20190255082 - Linderoth; Emma ;   et al.
2019-08-22
Fluorinated Imidazo[4,5-c]quinoline Derivatives As Inhibitors Of Bromodomain Containing Proteins
App 20190202825 - Slassi; Abdelmalik ;   et al.
2019-07-04
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
Grant 10,259,809 - Slassi , et al.
2019-04-16
Macrophage Stimulation In Cd47 Blockade Therapy
App 20190091290 - Lin; Gloria Hoi Ying ;   et al.
2019-03-28
Novel Fluorinated Quinazoline Derivatives As Egfr Inhibitors
App 20190016689 - Slassi; Abdelmalik ;   et al.
2019-01-17
Fluorinated Amide Derivatives And Their Uses As Therapeutic Agents
App 20180334425 - SLASSI; Abdelmalik
2018-11-22
Heterocycle Derivatives And Their Use For The Treatment Of Cns Disorders
App 20180312480 - Slassi; Abdelmalik
2018-11-01
Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
App 20180312563 - Uger; Robert Adam ;   et al.
2018-11-01
Treatment of CD47+ disease cells with SIRP alpha-Fc fusions
Grant 9,969,789 - Uger , et al. May 15, 2
2018-05-15
Novel Fluorinated Derivatives As Egfr Inhibitors Useful For Treating Cancers
App 20180050993 - Slassi; Abdelmalik ;   et al.
2018-02-22
Process For The Synthesis Of Difluoromethyl Ether-based Compounds
App 20180016227 - Slassi; Abdelmalik ;   et al.
2018-01-18
Fluorinated Imidazo[4,5-c]quinoline Derivatives As Inhibitors Of Bromodomain Containing Proteins
App 20180016271 - Slassi; Abdelmalik ;   et al.
2018-01-18
Fluorinated Epoxyketone-based Compounds And Uses Thereof As Proteasome Inhibitors
App 20160347792 - Slassi; Abdelmalik ;   et al.
2016-12-01
Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors
Grant 9,441,012 - Slassi , et al. September 13, 2
2016-09-13
Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
App 20150329616 - Uger; Robert Adam ;   et al.
2015-11-19
Multimeric Fc receptor polypeptides
Grant 8,729,247 - Hogarth , et al. May 20, 2
2014-05-20
HB-EGF Composition and Use Thereof to Treat a Condition Associated With Enhanced Urothelium Permeability
App 20130102532 - Uger; Robert ;   et al.
2013-04-25
Assay for Soluble CD200
App 20120264145 - Gorczynski; Reginald M. ;   et al.
2012-10-18
Assay for soluble CD200
Grant 8,206,897 - Gorczynski , et al. June 26, 2
2012-06-26
Methods of treating cancer by administering antibodies to CD200
Grant 8,187,598 - Gorczynski , et al. May 29, 2
2012-05-29
Methods And Compositions For Modulating Immunity
App 20110206668 - GORCZYNSKI; REGINALD M. ;   et al.
2011-08-25
Methods Of Treating Cancer By Administering Antibodies To Cd200
App 20110129466 - GORCZYNSKI; REGINALD M. ;   et al.
2011-06-02
Fc receptor modulating compounds and compositions
Grant 7,910,770 - Hogarth , et al. March 22, 2
2011-03-22
Methods and compositions for modulating immunity
Grant 7,902,151 - Gorczynski , et al. March 8, 2
2011-03-08
Methods of treating cancer by administering antibodies to CD200
Grant 7,887,798 - Gorczynski , et al. February 15, 2
2011-02-15
Methods and Compositions For Modulating Immunity
App 20090232825 - GORCZYNSKI; REGINALD M. ;   et al.
2009-09-17
Methods and compositions for modulating immunity
Grant 7,553,811 - Gorczynski , et al. June 30, 2
2009-06-30
Methods of Treating Cancer by Administering Antibodies to CD200
App 20090053222 - GORCZYNSKI; REGINALD M. ;   et al.
2009-02-26
Methods of treating cancer by administering antibodies to CD200
Grant 7,452,536 - Gorczynski , et al. November 18, 2
2008-11-18
Fc Receptor Modulating Compounds and Compositions
App 20080146632 - Hogarth; Mark Phillip ;   et al.
2008-06-19
CD200 receptors
Grant 7,368,535 - Gorczynski , et al. May 6, 2
2008-05-06
Fc.gamma.RIIa transgenic animal model for autoimmune disease
Grant 7,351,875 - Hogarth , et al. April 1, 2
2008-04-01
Fc receptor modulating compounds and compositions
Grant 7,332,631 - Hogarth , et al. February 19, 2
2008-02-19
Multimeric Fc Receptor Polypeptides
App 20080008700 - Hogarth; Phillip Mark ;   et al.
2008-01-10
MD-1 inhibitors as immune suppressants
Grant 7,291,330 - Gorczynski , et al. November 6, 2
2007-11-06
Methods and compositions for modulating tumor growth
Grant 7,238,352 - Gorczynski , et al. July 3, 2
2007-07-03
Methods of treating allergy by administering a CD200 protein
Grant 7,223,729 - Gorczynski May 29, 2
2007-05-29
Truncated CD200
Grant 7,205,386 - Gorczynski April 17, 2
2007-04-17
Transgenic animal containing CD200 and uses therefor
Grant 7,196,243 - Gorczynski March 27, 2
2007-03-27
Methods and compositions for modulating autoimmunity
Grant 6,984,625 - Gorczynski January 10, 2
2006-01-10
Methods of inhibiting immune response suppression by administering antibodies to OX-2
Grant 6,955,811 - Gorczynski , et al. October 18, 2
2005-10-18
Compositions comprising antibodies to human FgI2
App 20050169913 - Levy, Gary ;   et al.
2005-08-04
Methods and compositions for modulating immunity
App 20050048069 - Gorczynski, Reginald M. ;   et al.
2005-03-03
Treatment of chronic human viral hepatitis
App 20050042226 - Levy, Gary ;   et al.
2005-02-24
Methods of modulating immune coagulation
Grant 6,805,863 - Levy October 19, 2
2004-10-19
Use of OX-2 to inhibit fetal loss
Grant 6,749,854 - Gorczynski , et al. June 15, 2
2004-06-15
Use of OX-2 to suppress an immune response
Grant 6,652,858 - Gorczynski , et al. November 25, 2
2003-11-25
Fgl-2 knockout mice
Grant 6,642,433 - Levy , et al. November 4, 2
2003-11-04
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed